Novavax Inc (NASDAQ:NVAX)

7.25
Delayed Data
As of Sep 29
 +0.09 / +1.26%
Today’s Change
5.61
Today|||52-Week Range
25.66
-29.47%
Year-to-Date
Why Pfizer and BioNTech Stocks Zoomed Higher Today
Sep 29 / MotleyFool.com - Paid Partner Content
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
Sep 19 / MotleyFool.com - Paid Partner Content
Does This Message From Moderna Mean Bad News for Novavax?
Sep 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.16
Today’s open7.32
Day’s range7.16 - 7.68
Volume397,634
Average volume (3 months)8,161,242
Market cap$685.4M
Data as of 4:00pm ET, 09/29/2023

Growth & Valuation

Earnings growth (last year)+64.09%
Earnings growth (this year)+74.87%
Earnings growth (next 5 years)-69.66%
Revenue growth (last year)+72.89%
P/E ratioNM
Price/Sales0.41
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TVTXTravere Therapeutics...-0.03-0.33%
SAVACassava Sciences Inc-0.22-1.30%
RGNXRegenxbio Inc-1.21-6.84%
EDITEditas Medicine Inc+0.87+12.57%
Data as of 4:00pm ET, 09/29/2023

Financials

Next reporting dateNovember 2, 2023
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$2.0B
Annual profit (last year)-$657.9M
Net profit margin-33.20%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts